SCF ENCYCLOPEDIA ENTRY

ACUTE KIDNEY INJURY (AKI) — POSTPARTUM

SCF-RDOS Registry Code: SCF-RDOS-PPD-RENAL-001

Disease Type Classification: Postpartum Renal Disorder → Acute Organ Dysfunction Syndrome → Acute Kidney Injury (AKI)

SCF Classification Status: Maternal Renal Critical Care Syndrome

SCF Severity Classification: Acute Maternal Renal Failure Spectrum Disorder

Adaptive Module Activation

• Universal Core Module
• Renal Biology Expansion
• Critical Care Expansion
• Maternal Survival Biology Expansion
• Endothelial Biology Expansion
• Hemodynamic Biology Expansion
• Immunology Expansion
• Microcirculation Biology Expansion
• Mitochondrial Biology Expansion
• Multi-Organ Systems Expansion
• SCF Pathophysiology Protocol (Extended Version)
• SCF Universal Cross-System Analysis Module

1. SCOPE & POSITIONING

Definition

Acute Kidney Injury (AKI) is a syndrome characterized by an abrupt decline in renal filtration, tubular function, fluid regulation, electrolyte homeostasis, and metabolic waste clearance occurring during the postpartum period.

Postpartum AKI represents one of the most serious maternal complications and frequently serves as a central component of Maternal Critical Illness Syndrome (MCIS) and Multiple Organ Dysfunction Syndrome (MODS).

Within the SCF framework, AKI is classified as:

A renal homeostatic collapse syndrome characterized by disruption of glomerular filtration, tubular integrity, microvascular perfusion, and nephron bioenergetics resulting in progressive loss of fluid, electrolyte, metabolic, and systemic regulatory function.

2. SCOPE & CLINICAL POSITIONING

SCF Hierarchical Placement

Normal Renal Adaptation

↓

Renal Stress Response

↓

Acute Kidney Injury

↓

Acute Renal Failure

↓

MODS-Associated Renal Failure

↓

Maternal Survival System Collapse

Major Postpartum Associations

Hemodynamic Disorders

• Hemorrhagic Shock
• Postpartum Hypovolemic Shock
• Massive Obstetric Hemorrhage

Hypertensive Disorders

• HELLP Syndrome
• Severe Preeclampsia
• Postpartum Eclampsia
• Hypertensive Crisis

Infectious Disorders

• Puerperal Sepsis
• Septic Shock
• Postpartum Bacteremia

Coagulopathic Disorders

• DIC
• Obstetric Coagulopathy
• Thrombotic Microangiopathy

Critical Care Disorders

• ARDS
• MODS
• Maternal Critical Illness Syndrome

3. ETIOPATHOGENIC CORE

Central SCF Principle

AKI develops when renal adaptive mechanisms become incapable of maintaining nephron function in the presence of ischemic, inflammatory, toxic, thrombotic, or hemodynamic injury.

The syndrome reflects failure of:

• Renal perfusion regulation
• Glomerular filtration
• Tubular transport systems
• Electrolyte homeostasis
• Fluid balance
• Acid-base regulation
• Renal-endocrine signaling

Core SCF Equation

Renal Insult

Microvascular Dysfunction

Nephron Bioenergetic Failure

=

Acute Kidney Injury

4. ETIOLOGY AND TRIGGER CLUSTERS

Cluster A — Ischemic AKI

Associated Conditions:

• Hemorrhagic shock
• Severe hypotension
• Massive blood loss

Primary Failure:

Renal hypoperfusion

Cluster B — Septic AKI

Associated Conditions:

• Septic shock
• Puerperal sepsis

Primary Failure:

Inflammatory microvascular dysfunction

Cluster C — Hypertensive AKI

Associated Conditions:

• HELLP syndrome
• Severe preeclampsia
• Eclampsia

Primary Failure:

Endothelial injury

Cluster D — Coagulopathic AKI

Associated Conditions:

• DIC
• Thrombotic microangiopathy

Primary Failure:

Microvascular thrombosis

Cluster E — Nephrotoxic AKI

Associated Conditions:

• Drug toxicity
• Contrast-induced injury

Primary Failure:

Tubular damage

Cluster F — Critical Illness AKI

Associated Conditions:

• MODS
• ARDS
• MCIS

Primary Failure:

Systemic organ-network failure

5. SCF FAULT ARCHITECTURE

Tier I — Renal Stress Activation

Events:

• Reduced perfusion
• Inflammatory activation

Result:

Adaptive nephron response

Tier II — Microvascular Dysfunction

Features:

• Endothelial activation
• Reduced blood flow
• Capillary dysfunction

Result:

Renal oxygen deficit

Tier III — Tubular Injury

Features:

• ATP depletion
• Cellular swelling
• Oxidative stress

Result:

Tubular dysfunction

Tier IV — Acute Kidney Injury

Features:

• Reduced filtration
• Creatinine elevation
• Oliguria

Result:

Clinical AKI

Tier V — Acute Renal Failure

Features:

• Severe filtration failure
• Electrolyte abnormalities
• Fluid overload

Result:

Organ dysfunction

Tier VI — Renal Contribution to MODS

Features:

• Multi-organ interaction failure
• Systemic metabolic instability

Result:

Maternal survival threat

6. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Affected Pathways:

• Oxidative stress defense
• Endothelial resilience
• Tubular regeneration
• Inflammatory regulation

Transcriptomics

Activation of:

• Hypoxia-response genes
• NF-κB signaling
• Apoptosis pathways
• Repair mechanisms

Proteomics

Elevated Biomarkers:

• NGAL
• KIM-1
• Cystatin C
• IL-6
• TNF-α

Metabolomics

Features:

• ATP depletion
• Lactate accumulation
• Uremic metabolite buildup
• Oxidative stress

Endotheliomics

Features:

• Glycocalyx injury
• Microvascular rarefaction
• Perfusion abnormalities

Mitochondriomics

Features:

• Mitochondrial swelling
• Oxidative phosphorylation failure
• Energy collapse

Interactomics

Failure of:

• Kidney-heart communication
• Kidney-lung communication
• Kidney-immune system integration

7. SCF PATHOGENESIS FLOW

Maternal Trigger Event

↓

Renal Perfusion Disturbance

↓

Microvascular Dysfunction

↓

Tubular Hypoxia

↓

Mitochondrial Injury

↓

ATP Depletion

↓

Tubular Dysfunction

↓

Reduced Glomerular Filtration

↓

Acute Kidney Injury

↓

Electrolyte and Fluid Dysregulation

↓

Acute Renal Failure

↓

MODS

↓

Maternal Critical Illness Syndrome

8. SCF FUNCTIONAL MATRIX

9. SCF TRINITY FRAMEWORK

Structural Integrity Failure

Affected Structures:

• Glomeruli
• Tubules
• Renal microvasculature
• Interstitial tissue

Primary Failure:

Loss of nephron integrity

Energetic Integrity Failure

Affected Systems:

• Mitochondrial ATP generation
• Oxygen utilization pathways
• Tubular transport systems

Primary Failure:

Bioenergetic collapse

Informational Integrity Failure

Affected Systems:

• Renin-angiotensin signaling
• Fluid regulation pathways
• Electrolyte homeostasis networks

Primary Failure:

Loss of renal systemic coordination

10. SCF PATHOPHYSIOLOGY PROTOCOL — EXTENDED VERSION

Etiopathogenic Core

Acute disruption of nephron viability resulting in collapse of renal filtration and systemic homeostatic regulation.

SCF Fault Domains

1. Renal hypoperfusion
2. Endothelial dysfunction
3. Tubular injury
4. Filtration failure
5. Metabolic dysregulation
6. Organ-system interaction failure
7. Multi-organ progression

Trigger → Symptomatology → Fault Mapping

11. SCF THERAPEUTIC MECHANISMS (PCR BRAID)

PREVENTATIVE

Objectives

Prevent progression from renal stress to AKI.

Targets:

• Hemodynamic stabilization
• Infection prevention
• Blood pressure optimization
• Nephrotoxin avoidance

CURATIVE

Objectives

Restore nephron function and preserve renal viability.

Targets:

• Renal perfusion
• Inflammation
• Tubular injury
• Electrolyte imbalance

Clinical Interventions:

• Fluid optimization
• Hemodynamic support
• Sepsis treatment
• Correction of underlying cause
• Renal replacement therapy when indicated

RESTORATIVE

Objectives

Restore long-term renal resilience.

Targets:

• Tubular regeneration
• Endothelial recovery
• Mitochondrial restoration
• Fibrosis prevention

Potential SCF Strategies:

• Nephron regenerative platforms
• Mitochondrial rescue therapeutics
• Endothelial stabilization systems
• Precision renal recovery technologies

12. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Clinical Findings

Common signs:

• Oliguria
• Anuria
• Edema
• Hypertension
• Fluid overload

Laboratory Studies

• Serum creatinine
• BUN
• Electrolytes
• Urinalysis
• Urine protein assessment
• Cystatin C

Imaging

• Renal ultrasonography
• Doppler evaluation
• CT/MRI when indicated

Treatment

Supportive Management

• Volume management
• Electrolyte correction
• Acid-base management

Advanced Management

• ICU care
• Continuous renal replacement therapy (CRRT)
• Hemodialysis
• Multi-organ support

13. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Renal Injury

• NGAL
• KIM-1
• Cystatin C

Endothelial Injury

• Angiopoietin-2
• vWF

Inflammation

• IL-6
• TNF-α
• CRP

Bioenergetic Dysfunction

• Lactate
• Mitochondrial stress markers

Clinical Endpoints

Primary

• Renal recovery

Secondary

• Dialysis-free survival
• Organ preservation
• ICU-free days
• Maternal survival

FDA TRANSLATIONAL PATHWAY

Discovery

↓

Preclinical AKI Models

↓

IND Submission

↓

Phase I Safety

↓

Phase II Renal Recovery Studies

↓

Phase III AKI Outcome Trials

↓

NDA/BLA Submission

14. PROJECT RHENOVA — INTEGRATION PATHWAYS

RHENOVA-A

Renal Perfusion Restoration

RHENOVA-B

Tubular Protection

RHENOVA-C

Microvascular Recovery

RHENOVA-D

Mitochondrial Rescue

RHENOVA-E

Nephron Regeneration

RHENOVA-F

Long-Term Renal Preservation

15. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Early maternal AKI biomarker panels

Priority 2

Precision nephroprotection platforms

Priority 3

Mitochondrial rescue therapeutics

Priority 4

Endothelial restoration technologies

Priority 5

AI-enabled renal deterioration prediction

Priority 6

Nephron regeneration medicine

16. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Renal tubular cells lose energetic capacity and transport efficiency.

Tissue Layer

Microvascular dysfunction impairs oxygen and nutrient delivery throughout the nephron.

Organ Layer

The kidney progressively loses its ability to regulate fluid, electrolyte, and metabolic balance.

System Layer

Renal, cardiovascular, pulmonary, endocrine, and immune systems become increasingly desynchronized.

Whole-Organism Layer

The maternal organism experiences failure of one of its primary homeostatic control organs, leading to accumulation of toxins, metabolic instability, fluid imbalance, and escalation toward systemic critical illness.

17. SCF LAYMAN’S SUMMARY

Acute Kidney Injury (AKI) is a sudden decline in kidney function that can occur after severe postpartum complications such as major bleeding, infection, high blood pressure disorders, or critical illness.

In the SCF framework, AKI is viewed as a breakdown of the kidney’s ability to filter waste, regulate fluids, maintain electrolyte balance, and support overall body stability.

Common signs include:

• Reduced urine output
• Swelling
• Fatigue
• Shortness of breath
• Elevated blood tests indicating kidney dysfunction

Severe AKI can lead to fluid overload, dangerous electrolyte abnormalities, dialysis requirements, multiple organ dysfunction, and maternal death if not treated promptly.

SCF-RDOS INDICATION SUMMARY

INDEX

SCF Master Registry Classification

• SCF-RDOS-PPD-RENAL-001 — Acute Kidney Injury (AKI)
• SCF-RDOS-PPD-PULM-001 — Acute Respiratory Distress Syndrome (ARDS)
• SCF-RDOS-PPD-HEMO-001 — Hemorrhagic Shock
• SCF-RDOS-PPD-INF-011 — Septic Shock
• SCF-RDOS-PPD-CRIT-001 — Multiple Organ Dysfunction Syndrome (MODS)
• SCF-RDOS-PPD-CRIT-002 — Maternal Critical Illness Syndrome (MCIS)

Domain Pathway

Postpartum Disorders → Renal Disorders → Acute Organ Dysfunction Syndromes → Acute Kidney Injury

Adaptive Modules Applied

Universal Core Module + Renal Biology Expansion + Critical Care Expansion + Maternal Survival Biology Expansion + Endothelial Biology Expansion + Hemodynamic Biology Expansion + Mitochondrial Biology Expansion + Multi-Organ Systems Expansion

SCF Encyclopedia Series

Maternal Postpartum Disorders Encyclopedia (Renal Medicine, Critical Care Nephrology, Maternal Survival Biology & Systems Pathophysiology Volume) — Version 1.0.0